Annals of blood最新文献

筛选
英文 中文
Making every question count: the impact of temporary donor deferral for suspected acute retroviral syndrome 让每个问题都有价值:暂时推迟疑似急性逆转录病毒综合征捐献者的影响
Annals of blood Pub Date : 2024-03-01 DOI: 10.21037/aob-23-16
Rachel E. Colbran, Melinda M. Dean, R. Harley, Robert L. Flower, Glen Shuttleworth, C. Styles, Helen M. Faddy
{"title":"Making every question count: the impact of temporary donor deferral for suspected acute retroviral syndrome","authors":"Rachel E. Colbran, Melinda M. Dean, R. Harley, Robert L. Flower, Glen Shuttleworth, C. Styles, Helen M. Faddy","doi":"10.21037/aob-23-16","DOIUrl":"https://doi.org/10.21037/aob-23-16","url":null,"abstract":"Background: Blood donor history questionnaires are used world-wide to detect blood supply and donor safety risks. Donors are less likely to return to donate blood following deferral, therefore removing questions with limited impact on safety would likely improve donor satisfaction and donation rates. Early human immunodeficiency virus (HIV) infection can manifest as acute retroviral syndrome (ARS). This study aimed to evaluate the impact of questioning and deferring blood donors for self-reported symptoms of ARS on Australian blood transfusion safety. Methods: A retrospective analysis of Australian Red Cross Lifeblood databases for the 17-year period, 2000–2016, was undertaken. Voluntary Australian blood donors who reported rash and lymphadenopathy on the donor questionnaire (DQ) were determined at risk of ARS and thus HIV. The proportion of donors deferred for possible ARS, the proportion who later returned, and donor return time for ARS and other 12-month deferrals was assessed. HIV status on subsequent donation in ARS declaring donors and proportion of HIV-positive donors with ARS-like symptoms was also reviewed. Results: Of donors who declared possible ARS, 65.56% [95% confidence interval (CI): 55.74–75.37%] were deferred and only 22.34% (95% CI: 17.40–27.29%) of deferred donors later returned. Compared to other 12-month deferral categories, donors deferred for possible ARS were less likely to return. No donor who declared possible ARS and subsequently donated tested HIV-positive. Moreover, no donors who tested HIV-positive reported both rash and lymphadenopathy in combination. Conclusions: The ARS question does not effectively differentiate HIV-positive from HIV-negative donors. The continued questioning of donors about ARS, through a self-reported combination of rash and lymphadenopathy, resulted in loss of donors who were unlikely to pose a threat to transfusion safety.","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":"77 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economics of patient blood management in the United States: a narrative review 美国病人血液管理的经济学:叙述性综述
Annals of blood Pub Date : 2024-03-01 DOI: 10.21037/aob-22-35
Shaughn Nalezinski, Mary Berg, Crystal Labrecque
{"title":"Economics of patient blood management in the United States: a narrative review","authors":"Shaughn Nalezinski, Mary Berg, Crystal Labrecque","doi":"10.21037/aob-22-35","DOIUrl":"https://doi.org/10.21037/aob-22-35","url":null,"abstract":"Background and Objective: Patient blood management (PBM) programs have recently been defined as ‘a patient-centered, systemic, evidence-based approach to improve patient outcomes by managing and preserving a patient’s own blood, while promoting patient safety and empowerment’. Many benefits are associated with developing a PBM program. These include reducing donor exposure, ensuring a safe blood supply, and potential cost savings from utilizing alternative therapies. Once blood is collected, it must be processed and tested for immunohematologic and transfusion-transmitted disease markers. The collection, testing, processing, and manufacturing of blood components contribute to their increasing cost. In the United States (U.S.), the cost associated with manufacturing blood components is then transferred to the transfusion services that acquire the components. The transfusion service then performs additional testing on the blood/blood component. The component is then priced for the recipient,","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":"21 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140084611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An overview of serology and molecular biology of the Rh blood group system Rh 血型系统的血清学和分子生物学概述
Annals of blood Pub Date : 2024-03-01 DOI: 10.21037/aob-2023-03
Lilian Castilho
{"title":"An overview of serology and molecular biology of the Rh blood group system","authors":"Lilian Castilho","doi":"10.21037/aob-2023-03","DOIUrl":"https://doi.org/10.21037/aob-2023-03","url":null,"abstract":"","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":" 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140091598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood products other than packed red blood cells in extracorporeal membrane oxygenation: guidelines, local protocols, and outcomes—a narrative review 体外膜氧合中包装红细胞以外的血液制品:指南、地方协议和结果--叙述性综述
Annals of blood Pub Date : 2024-03-01 DOI: 10.21037/aob-21-82
Hussam Elmelliti, Muhammad Abd Ur Rehman, Ahmed Al-Sukal, H. Akram, A. A. Hssain
{"title":"Blood products other than packed red blood cells in extracorporeal membrane oxygenation: guidelines, local protocols, and outcomes—a narrative review","authors":"Hussam Elmelliti, Muhammad Abd Ur Rehman, Ahmed Al-Sukal, H. Akram, A. A. Hssain","doi":"10.21037/aob-21-82","DOIUrl":"https://doi.org/10.21037/aob-21-82","url":null,"abstract":"Background and Objective: Blood Product transfusion is often required during extracorporeal membrane oxygenation (ECMO) support for several reasons. Most of the available data and literature have assessed packed red blood cells (PRBCs) transfusion during extracorporeal support, however it is key to define the threshold for the variability of other blood products available for transfusion. This review aims to highlight published data supporting blood product transfusion, other than PRBCs, in patients on ECMO support, including guidelines, local protocols, and patient outcomes. Methods: PubMed and Google Scholar were primarily used to access the targeted literature published until December 2022. We have also used authoritative text, published guidelines, and expert consensus. The literature on platelets, fresh frozen plasma (FFP), cryoprecipitate, albumin, and activated recombinant factor VII (rFVIIa) was summarized separately. Key Content and Findings: Platelets, FFP, and cryoprecipitate, were discussed in detail with their guidelines and recommended dosage, while albumin and rFVIIa are discussed briefly, primarily due to lack of literature. The relevance of viscoelastic clotting tests to blood product transfusion were also reviewed. In emergency setting, ECMO circuits can be primed with crystalloid while cross-matching blood is being prepared. Albumin can be used as an additive to the primes as it increases the circuit life and prevents protein loss by adding oncotic pressure to the prime. The average platelet units transfused directly correlated with the type of ECMO. Platelet transfusion increases the platelet count by 30,000–100,000/μL. If the international normalized ratio (INR) is greater than 1.5–2.0 or if there is significant bleeding, FFP can be given in aliquots of 10 mL/kg. Cryoprecipitate is given at a dose of 5 mL/kg of body weight if the fibrinogen level is less than 100–150 mg/dL and will increase the fibrinogen concentration by 50 mg/dL/10 kg of body weight. Thromboelastography (TEG), and thromboelastometry (TEM) reduce the requirement for blood product transfusion in bleeding patients. Conclusions: This review has highlighted the lack of data available regarding non-PRBC blood product transfusions and the appropriate therapy practices and preventive measures in ECMO patients. Further research is warranted to define and guide blood product transfusion thresholds, management practices, and limitations in ECMO patients.","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":"24 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140082928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sticky platelet syndrome—diagnostic issues and controversies 粘稠血小板综合征--诊断问题和争议
Annals of blood Pub Date : 2024-03-01 DOI: 10.21037/aob-22-49
Petr Kessler, Lenka Peliskova, Jitka Prokopova
{"title":"Sticky platelet syndrome—diagnostic issues and controversies","authors":"Petr Kessler, Lenka Peliskova, Jitka Prokopova","doi":"10.21037/aob-22-49","DOIUrl":"https://doi.org/10.21037/aob-22-49","url":null,"abstract":"","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":"96 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140086706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A narrative review of clinical biomarkers predicting outcome of immune-mediated thrombotic thrombocytopenic purpura 预测免疫介导的血栓性血小板减少性紫癜预后的临床生物标志物综述
Annals of blood Pub Date : 2023-12-01 DOI: 10.21037/aob-23-17
Ruinan Lu
{"title":"A narrative review of clinical biomarkers predicting outcome of immune-mediated thrombotic thrombocytopenic purpura","authors":"Ruinan Lu","doi":"10.21037/aob-23-17","DOIUrl":"https://doi.org/10.21037/aob-23-17","url":null,"abstract":"","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":" 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138619153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implication of novel RH alleles in blood transfusion therapy 新型 RH 等位基因对输血治疗的影响
Annals of blood Pub Date : 2023-12-01 DOI: 10.21037/aob-23-26
Lilian Castilho
{"title":"Implication of novel RH alleles in blood transfusion therapy","authors":"Lilian Castilho","doi":"10.21037/aob-23-26","DOIUrl":"https://doi.org/10.21037/aob-23-26","url":null,"abstract":"","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138627450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RHD molecular analysis—from discovery to next generation sequencing RHD 分子分析--从发现到新一代测序
Annals of blood Pub Date : 2023-12-01 DOI: 10.21037/aob-22-41
Tracey E. Madgett, Wajnat A. Tounsi, A. J. Halawani, N. Avent
{"title":"RHD molecular analysis—from discovery to next generation sequencing","authors":"Tracey E. Madgett, Wajnat A. Tounsi, A. J. Halawani, N. Avent","doi":"10.21037/aob-22-41","DOIUrl":"https://doi.org/10.21037/aob-22-41","url":null,"abstract":": This review traces the evolution of RHD genotyping from the very early days of the discovery of Rh polypeptides in 1982, and the pioneering work of the late 1980s and early 1990s that made the whole approach of RH genotyping possible. This work is often overlooked in contemporary Rh literature with citations of reviews being used which often do not give the complete background story. We have attempted to rectify this here. This review focuses primarily on RHD genotyping, primarily because of space constraints not to include RHCE but also because RHD is of greater clinical significance. In Europe many countries offer routine non-invasive prenatal RHD screening to direct the use of prophylactic anti-D to mothers that require it-namely are carrying D-positive fetuses. The genotyping approach is empirical (and wisely so) and any potential variant identified in this process is treated as D-positive. In such cases although sometimes unnecessary administration of prophylactic anti-D may be given, it only reflects the situation that predated mass scale non-invasive testing, and many countries not offering RHD screening. The complexity of the RHD gene and the known plethora of D variants (partial, weak D-elute and multiple genetic mechanisms generating the D-negative phenotype) are explored but only inasmuch as the technology to detect them is discussed. By far the most powerful means of accurate RHD genotyping, so called gold standard testing is next-generation sequencing although our discussion is tempered by several caveats mainly involving the rapid bioinformatic determination of a D variant from its resultant sequence. We stress however that next generation sequencing (NGS) offers the substantial advantage over other conventional RHD genotyping strategies in that novel variants can be identified whereas other methods require that the variant has been previously described so as to direct sequence specific analysis.","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":"115 42","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serological analysis of Rh antigens: how far can we go? Rh 抗原血清学分析:我们能走多远?
Annals of blood Pub Date : 2023-12-01 DOI: 10.21037/aob-23-30
Veera Sekaran Nadarajan
{"title":"Serological analysis of Rh antigens: how far can we go?","authors":"Veera Sekaran Nadarajan","doi":"10.21037/aob-23-30","DOIUrl":"https://doi.org/10.21037/aob-23-30","url":null,"abstract":"","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":" 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138616614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive value of the lactate dehydrogenase-to-albumin ratio (LAR) in classical Hodgkin’s lymphoma 经典霍奇金淋巴瘤中乳酸脱氢酶与白蛋白比率 (LAR) 的预测价值
Annals of blood Pub Date : 2023-12-01 DOI: 10.21037/aob-23-24
Elba Nydia Reyes-Pérez, Lisette Maricruz Flores-Cuevas, Gustavo Martínez-Mier, Luis Eduardo Chávez-Güitrón, María Concepción Martínez-Jiménez, Martha Audelo-Guzmán, Jacqueline Calderón-García, J. M. Reyes-Ruiz
{"title":"Predictive value of the lactate dehydrogenase-to-albumin ratio (LAR) in classical Hodgkin’s lymphoma","authors":"Elba Nydia Reyes-Pérez, Lisette Maricruz Flores-Cuevas, Gustavo Martínez-Mier, Luis Eduardo Chávez-Güitrón, María Concepción Martínez-Jiménez, Martha Audelo-Guzmán, Jacqueline Calderón-García, J. M. Reyes-Ruiz","doi":"10.21037/aob-23-24","DOIUrl":"https://doi.org/10.21037/aob-23-24","url":null,"abstract":"","PeriodicalId":72211,"journal":{"name":"Annals of blood","volume":" 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138621284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信